Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

AI Replacing Doctors? Utah Startup & the Future of Healthcare

February 20, 2026 Dr. Michael Lee – Health Editor Health

Biotech investor Robert Nelsen predicted at a live recording of STAT’s “Readout LOUD” podcast last month in San Francisco that artificial intelligence will ultimately replace doctors, asserting that AI is already superior to “most of [his] doctors.” The controversial statement, made during a J.P. Morgan Healthcare Conference event, sparked debate online, but Nelsen reaffirmed his position on X.

Nelsen’s forecast coincides with increasing exploration of AI’s role in healthcare, including automating tasks traditionally performed by physicians. Doctronic, a startup, is developing an AI system designed to renew prescriptions. Utah has taken the step of allowing Doctronic’s chatbot to do so, enacting a waiver of some state regulations governing the practice of medicine.

The functionality and regulatory implications of Doctronic’s “AI Doctor” were discussed on a recent episode of STAT’s “STATus Report.” Host Alex Hogan interviewed STAT health tech reporter Mario Aguilar about the chatbot’s operation, the argument that it falls outside the Food and Drug Administration’s regulatory purview, and the concerns raised by some medical experts.

The “Readout LOUD” podcast, featuring Nelsen and Novo Nordisk CEO Mike Doustdar, was a live taping from the J.P. Morgan Healthcare Conference (#JPM26). The event, hosted by STAT, drew attention to the intersection of biotechnology, venture capital, and emerging technologies like AI. The podcast is a regular feature of STAT, offering insights into the healthcare industry.

The discussion surrounding AI and healthcare comes as the industry grapples with the potential for technological disruption. The implications of AI-driven prescription renewals, and the regulatory challenges they present, remain a subject of ongoing debate.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • Dapagliflozin Improves Prognosis After TAVR Regardless of Ventricular Function
  • Understanding Overprescription: Not Everyone Is Overprescribed

Related

Artificial intelligence, health tech, pharmaceuticals

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: office@world-today-news.com

Privacy Policy Terms of Service